Bone Biologics Corp. Total current liabilities

Total current liabilities of BBLG for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total current liabilities growth rates and interactive chart.


Highlights and Quick Summary

  • Total current liabilities for the quarter ending September 30, 2022 was $800 Thousand (a 1032.44% increase compared to previous quarter)
  • Year-over-year quarterly Total current liabilities increased by 700.3%
  • Annual Total current liabilities for 2021 was $99.9 Thousand (a -99.27% decrease from previous year)
  • Annual Total current liabilities for 2020 was $13.7 Million (a 2267.27% increase from previous year)
  • Annual Total current liabilities for 2019 was $578 Thousand (a -94.0% decrease from previous year)
Visit stockrow.com/BBLG for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total current liabilities of Bone Biologics Corp.

Most recent Total current liabilitiesof BBLG including historical data for past 10 years.

Interactive Chart of Total current liabilities of Bone Biologics Corp.

Bone Biologics Corp. Total current liabilities for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.8 $0.07 $0.05
2021 $0.1 $0.1 $14.62 $14.2 $0.1
2020 $13.69 $13.24 $12.85 $13.69
2019 $0.58 $0.58
2018 $9.64
2017 $0.96
2016 $1.5

Business Profile of Bone Biologics Corp.

Sector: Healthcare
Industry: Medical Devices